De Braekeleer K, Corthout J
Service de Contrôle des Médicaments APB, Bruxelles.
J Pharm Belg. 2008 Sep;63(3):78-83.
Preparations containing lisinopril and the combination lisinopril/hydrochlorothiazide, and formulated as tablets were evaluated with different tests, including in vitro dissolution, assay and content uniformity, and determination of related compounds. The analytical methods were previously validated according to international guidelines. All examined products complied with the postulated requirements.
对含赖诺普利以及赖诺普利/氢氯噻嗪复方制剂的片剂进行了不同测试评估，包括体外溶出度、含量测定和含量均匀度以及有关物质的测定。分析方法先前已根据国际指南进行验证。所有检验产品均符合规定要求。
